First Light Diagnostics is developing breakthrough automated medical diagnostic products for rapid, sensitive, and cost-effective detection of HAI.
First FDA cleared product based on the Company's proprietary MultiPath technology
First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening a ...
Funding Supports Continued Development of the SensiTox™ B. anthracis Toxin Test
Test processing on the MultiPath Analyzer
Life Sciences Veteran Andrew Wilsack Joins Team
First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening ...
First Light Diagnostics, Inc., a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threaten ...
Seasoned Industry Veteran to Take Company Through Next Phase of Operations
For development of the breakthrough MultiPath platform and culture-free, anti-microbial susceptibility tests
First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening, ...
First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive and cost-effective diagnosis of life-threatening, a ...
Commits to deliver platform to enable targeted treatment at the onset of infection
Two-day event highlights investment trends and opportunities in Life Sciences
New Senior VP of R&D and Regulatory Affairs will help guide product development and regulatory clearance.